Refining Tumor Mutational Burden as a Predictive Biomarker for Pembrolizumab: A Real-World Analysis in Japanese Patients.
This study evaluated tumor mutational burden (TMB) as a real-world predictor of pembrolizumab efficacy in a large Japane...
This study evaluated tumor mutational burden (TMB) as a real-world predictor of pembrolizumab efficacy in a large Japane...
This publication evaluates thromboembolic risk with cabozantinib using both trial-level and real-world data. Design: -...
This review discusses how cancer cells meet their energy needs and how dietary interventions might influence tumor metab...
This narrative review focuses on end-of-life (EOL) care for Black/African American women with breast and gynecologic can...
This review frames cancer as a disease of the human “metaorganism,” emphasizing that host cells and the microbiome j...
This review discusses the rationale and current status of vaccines targeting shared oncogenic driver mutations as a canc...